trending Market Intelligence /marketintelligence/en/news-insights/trending/vud7daiqnibxljqbnz6sgg2 content esgSubNav
In This List

Arix Bioscience CEO transitioning to chief investment officer

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Arix Bioscience CEO transitioning to chief investment officer

Arix Bioscience PLC said CEO Joe Anderson will become the chief investment officer.

The company added that Anderson will also step down from the board, effective Sept. 4.

Executive Chairman Jonathan Peacock will assume corporate and operating responsibilities and will work with the board to recruit a new CEO.

London-based Arix is an investment company that invests in medical innovation comprising healthcare and the life sciences.